Related Experiment Video
Updated: Jun 27, 2026

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Advancements in hepatic haemangioma surgery: An update-review of protocols, techniques, and postoperative outcomes
Sofia Rozani1, Vasileios Vougas2
1Second Department of Surgery, Aretaieio University Hospital, National and Kapodistrian University of Athens, Athens 11528, Greece. sofrozan@gmail.com.
Abstract:
Hepatic haemangiomas are the most common benign liver lesions, often found on incidental imaging. Although often asymptomatic, they can lead to abdominal pain, bleeding and rarely rupture. Surgery is indicated in symptomatic cases or in case of complications. To evaluate current surgical management strategies for hepatic haemangiomas, focusing on recent advances in minimally invasive and robotic surgery, imaging, embolization, and perioperative care. It also explores the emerging role of artificial intelligence (AI) in preoperative planning, intraoperative guidance, and postoperative monitoring, and proposes evidence-based management algorithms reflecting current practice and future directions. This minireview synthesizes the recent literature on the surgical management of hepatic haemangiomas, with emphasis on advances in surgical strategies, perioperative protocols available to date, and postoperative care. The contemporary role of diagnostic imaging and AI in improving preoperative evaluation is also explored. Advances in minimally invasive techniques, improved intraoperative navigation and improved recovery protocols have significantly reduced surgical morbidity. The integration of AI has improved lesion characterization and surgical planning. Current surgical procedures, such as laparoscopic incision and robot-assisted resections, have demonstrated favorable outcomes in selected patients.

